Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo.

Fallowfield, Jonathan A; Hayden, Annette L; Snowdon, Victoria K; Aucott, Rebecca L; Stutchfield, Ben M; Mole, Damian J; Pellicoro, Antonella; Gordon-Walker, Timothy T; Henke, Alexander; Schrader, Joerg; Trivedi, Palak J; Princivalle, Marc; Forbes, Stuart J; Collins, Jane E; Iredale, John P

Fallowfield, Jonathan A; Hayden, Annette L; Snowdon, Victoria K; Aucott, Rebecca L; Stutchfield, Ben M; Mole, Damian J; Pellicoro, Antonella; Gordon-Walker, Timothy T; Henke, Alexander; Schrader, Joerg; Trivedi, Palak J; Princivalle, Marc; Forbes, Stuart J; Collins, Jane E; Iredale, John P.

Affiliation

Fallowfield JA; Medical Research Council/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.

Hepatology ; 59(4): 1492-504, 2014 Apr.

Article in En | MEDLINE | ID: mdl-23873655

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Relaxin / Myofibroblasts / Hypertension, Portal / Liver / Liver Cirrhosis Limits: Animals / Humans / Male Language: En Journal: Hepatology Year: 2014 Document type: Article Affiliation country:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google